Cargando…
Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma
BACKGROUND: Previous studies comparing primary tumor resection (PTR) to palliative treatment for advanced-stage pancreatic ductal adenocarcinoma (PDA) were limited by strong selection bias. We used multiple methods to control for confounding and selection bias to estimate the effect of PTR on surviv...
Autores principales: | Sun, Ke, Li, Wei, Han, Jun, Wu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676580/ https://www.ncbi.nlm.nih.gov/pubmed/31370893 http://dx.doi.org/10.1186/s12885-019-5966-9 |
Ejemplares similares
-
Resection of metachronous pancreatic cancer 4 years after pancreaticoduodenectomy for stage III pancreatic adenocarcinoma
por: Hamner, John B., et al.
Publicado: (2015) -
The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma
por: Ling, Qi, et al.
Publicado: (2017) -
Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection
por: He, Chaobin, et al.
Publicado: (2021) -
Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System
por: Ren, Hu, et al.
Publicado: (2020) -
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
por: Zhu, Lingyu, et al.
Publicado: (2023)